99.1 |
99.2 |
99.3 |
99.4 |
Meeting Type :
|
Annual General and Special Meeting
|
Record Date for Notice of Meeting :
|
August 16, 2023
|
Record Date for Voting (if applicable) :
|
August 16, 2023
|
Beneficial Ownership Determination Date :
|
August 16, 2023
|
Meeting Date :
|
September 22, 2023
|
Meeting Location (if available) :
|
Vancouver, BC
|
Issuer sending proxy related materials directly to NOBO :
|
Yes
|
Issuer paying for delivery to OBO :
|
No
|
Notice and Access (NAA) Requirements
|
|
NAA for Beneficial Holders
|
No
|
NAA for Registered Holders
|
No
|
Voting Security Details:
|
||
Description
|
CUSIP Number
|
ISIN
|
COMMON SHARES
|
76027P400
|
CA76027P4006
|
•
|
RepliCel’s three cell therapy products have now been tested in over 100 patients in four countries on three continents.
|
•
|
RepliCel now has key strategic regional partners each of which are now investing heavily in the further clinical testing and development of RepliCel’s products for their markets. Data
from each of the clinical programs will strengthen the product development initiatives for RepliCel and its other partners worldwide.
|
•
|
RepliCel’s three cell therapy products have now been tested in over 100 patients in four countries on three continents.
|
•
|
RepliCel now has key strategic regional partners each of which are now investing heavily in the further clinical testing and
development of RepliCel’s products for their markets. Data from each of the clinical programs will strengthen the product development initiatives for RepliCel and its other partners worldwide.
|